46
MEDYA
TR
EN
Home
Genel
News Detail
Morning Star
May 27, 2026
|
10:00
Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026
...
Full Story at Source
Related News
U.S. Futures, European Stocks Climb
SK Hynix, Micron Join Trillion-Dollar Club
LKQ Investors Have Opportunity to Lead LKQ Corporation Securities Fraud Lawsuit with the Schall Law Firm
Only 65 percent of employers taking action on women's health at work but progress remains fragmented, reveals Kearney
